Confirmation of combination hormone blocking therapy approach for recurrent prostate cancer
CANCER DIGEST – Jan. 28, 2024 – A new multi-center study, led by Rahul Aggarwall, MD, a professor at UCSF School of Medicine, has shown...
![](https://static.wixstatic.com/media/41d313_4c8a696f767c4f2286ebb1829dc01484~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/41d313_4c8a696f767c4f2286ebb1829dc01484~mv2.webp)
![Confirmation of combination hormone blocking therapy approach for recurrent prostate cancer](https://static.wixstatic.com/media/41d313_4c8a696f767c4f2286ebb1829dc01484~mv2.jpg/v1/fill/w_319,h_240,fp_0.50_0.50,q_90,enc_auto/41d313_4c8a696f767c4f2286ebb1829dc01484~mv2.webp)
Combination therapy for recurrent prostate cancer may slow progression and extend survival
CANCER DIGEST – Oct. 21, 2023 – Men with aggressive recurrent prostate cancer who were given a combination therapy aimed at hormone...
![](https://static.wixstatic.com/media/41d313_3dd87652cd7a4c0bbd29d031d2d52234~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/41d313_3dd87652cd7a4c0bbd29d031d2d52234~mv2.webp)
![Combination therapy for recurrent prostate cancer may slow progression and extend survival](https://static.wixstatic.com/media/41d313_3dd87652cd7a4c0bbd29d031d2d52234~mv2.jpg/v1/fill/w_272,h_240,fp_0.50_0.50,q_90,enc_auto/41d313_3dd87652cd7a4c0bbd29d031d2d52234~mv2.webp)